FDA.reportPublic FDA data

solosec 2 GM Oral Granules

RxCUI
1946698
RxNorm name
solosec 2 GM Oral Granules
Display name
solosec 2 GM Oral Granules
Full name
solosec 2 GM Oral Granules
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SolosecSECNIDAZOLEEvofem Inc.056485b6-8bba-4a21-ae00-cdb4e7ae4bfa2025-02-19Warnings, Adverse reactionsExact identifier
rxcui: 1946698

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
056485b6-8bba-4a21-ae00-cdb4e7ae4bfasolosec 2 GM Oral Granules [PSN] · secnidazole 2000 MG Oral Granules [Solosec] [SBD] · Solosec 2 GM Oral Granules [SY] · Solosec 2000 MG Oral Granules [SY]41These highlights do not include all the information needed to use SOLOSEC ® safely and effectively. See full prescribing information for SOLOSEC. SOLOSEC ® (secnidazole) oral granules Initial U.S. Approval: 201720250219